Rana Hilal, MD
Resident Memory T Cells in Non-segmental Vitiligo
Vinod Kumar, PhD
Role of CXCR3 and Its Primary Ligands in Segmental and Non-segmental Vitiligo Pathogenesis
Davinder Parsad, MD, FRCP
Controversies & Challenges in the Pathophysiology of Vitiligo
Interview and audience Q&A
Samia Esmat, MD
Targeting Innate & Adaptive Immunity as a Therapeutic Approach
Interview and audience Q&A
Yvon Gauthier, MD
Segmental Vitiligo Pattern and Cutaneous Arterial Vessel Mapping: An Anatomoclinical and Physiopathological Approach
Iltefat Hamzavi, MD
Outlining Vitiligo: Overview, Epidemiology & Burden of Disease
Interview and audience Q&A
Pfizer Satellite Meeting
Pfizer Satellite Meeting
Vitiligo Talks: Understanding the Burden of Disease & Pathophysiology
Panel discussion and audience Q&A
Amit G. Pandya, MD
Invited Speaker: Update on Jak Inhibitors For Vitiligo
Abburi Ramaiah, PhD
Combinatorial Therapies With Basic Fibroblast Growth Factor Related Agonist Peptides to Treat Vitiligo
Thierry Passeron, MD, PhD
Effect of Ruxolitinib Cream on Achievement of VASI50 by Body Region: Week 52 Pooled Analysis of the TRuE-V Phase 3 Studies
